Registry of Lobbyists

Registration - Consultant

GlaxoSmithKline Inc. / Eric Elvidge, Consultant

Registration Information

Client name: GlaxoSmithKline Inc.
Lobbyist name: Eric Elvidge, Consultant
Initial registration start date: 2005-11-11
Registration status: Inactive
Registration Number: 778799-5981

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 2 of 6 (2006-05-05 to 2006-12-22)

Version 2 of 6 (2006-05-05 to 2006-12-22) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: Eric Elvidge    Lobbyist business address
Consulting firm: Blake, Cassels & Graydon LLP
2000 - 45 O'Connor Street
Ottawa, ON  K1P 1A4
Canada
Position: Partner
Telephone number: 613-788-2238  
Fax number: 613-788-2247  
 
Former public office holder: No
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: GlaxoSmithKline Inc.
7333 Mississauga Road North
Mississauga, ON  L5N 6L4
Canada
Telephone number:
Fax number: 905-819-3087  
 
Client Representative: Patrick McGrade
 
The client is a subsidiary of the following parent companies: GlaxoSmithKline plc
980 Great West Road
Brentford, Middlesex TW89GS
United Kingdom

Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Industry Canada, Investment Division of Industry Canada
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Government Contract Pursued Proposed acquisition by GlaxoSmithKline Inc. of ID Biomedical Corporation




Date Modified: